XML 49 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of payment award, employee stock purchase plan, valuation assumptions The following table summarizes the assumptions used to compute the current fair value of our cash-settled SARs:
 
 
December 29, 2018
 
December 30, 2017
Expected volatility
 
Not applicable
 
33.80
%
Risk-free interest rate
 
Not applicable
 
1.55
%
Expected term (in years)
 
Not applicable
 
0.54

Expected dividend yield
 
Not applicable
 
Not applicable

Schedule of activity for restricted stock and restricted stock units The following table summarizes activity for our restricted stock awards during fiscal 2018:
 
Restricted Stock Awards
 
Number of
Awards
 
Weighted
Average Fair
Value
Outstanding as of December 30, 2017
16,667

 
$
9.90

Granted

 

Vested (1)
(16,667
)
 
9.90

Forfeited

 

Outstanding as of December 29, 2018

 
$

(1) 
The total fair value vested in fiscal 2018, fiscal 2017, and fiscal 2016 was $0.2 million, $1.2 million, and $1.1 million, respectively.The following table summarizes activity for our restricted stock units during fiscal 2018:
 
Restricted Stock Units
 
Number of
Awards
 
Weighted
Average Fair
Value
Outstanding as of December 30, 2017
242,362

 
$
7.41

Granted
198,487

 
33.46

Vested (1)
(228,029
)
 
7.42

Forfeited
(18,598
)
 
15.06

Outstanding as of December 29, 2018
194,222

 
$
33.29

(1) 
The total fair value of restricted stock units vested in fiscal 2018, 2017, and 2016 was $1.7 million, $0.7 million and $0.6 million, respectively.
Schedule of activity for performance shares The following table summarizes activity for our performance share awards during fiscal 2018:
 
Performance Shares
 
Number of
Awards
 
Weighted
Average Fair
Value
Outstanding as of December 30, 2017
60,000

 
$
9.29

Granted

 

Vested (1)
(59,000
)
 
9.28

Forfeited
(1,000
)
 
9.80

Outstanding at December 29, 2018

 
$

(1) 
No performance share awards vested in fiscal 2017. The total fair value vested in fiscal 2018 and 2016 was $0.5 million and $1.6 million, respectively
Schedule of outstanding employee stock options The tables below summarize activity and include certain additional information related to our outstanding stock options granted under the 2004 Plan and 2006 Plan for the year ended December 29, 2018. The maximum contractual term for stock options was ten years from the grant date, and the remaining outstanding final tranche of options as of December 29, 2018, presented below, expired on March 10, 2018. There were no new employee stock option grants and no stock option exercises during fiscal years 2018, 2017, and 2016.
 
Options
 
Shares
 
Weighted
Average
Exercise
Price
Outstanding as of December 30, 2017
75,000

 
$
46.60

Granted

 

Exercised

 

Forfeited

 

Expired
(75,000
)
 
46.60

Outstanding and exercisable as of December 29, 2018

 
$

Schedule of expense for restricted stock, performance shares, restricted stock units, and stock options, net of estimated forfeitures Total share-based compensation expense from our share-based awards was as follows:
 
December 29, 2018
 
December 30, 2017
 
December 31, 2016
 
(In thousands)
Restricted Stock and Restricted Stock Units
$
1,350

 
$
1,406

 
$
1,872

Performance Shares
788

 
452

 
92

Cash-settled Stock Appreciation Rights
13,173

 
622

 
375

Stock Options

 

 

Total
$
15,311

 
$
2,480

 
$
2,339